Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe Fleischmann

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
British Journal of Cancer|September 22, 2022
Genomic landscape of pleural and peritoneal mesothelioma tumoursStefanie Hiltbrunner, Zoe Fleischmann, Ethan S Sokol, et al.
The Oncologist|August 17, 2023
Increased KRAS G12C Prevalence, High Tumor Mutational Burden, and Specific Mutational Signatures Are Associated With MUTYH Mutations: A Pan-Cancer AnalysisUmut Disel, Smruthy Sivakumar, Tim Pham, et al.
BMC Bioinformatics|March 21, 2022
3GOLD: optimized Levenshtein distance for clustering third-generation sequencing dataRobert Logan, Zoe Fleischmann, Sofia Annis, et al.
JAMA Network Open|March 23, 2022
Prevalence of UV Mutational Signatures Among Cutaneous Primary TumorsDouglas A Mata, Erik A Williams, Ethan Sokol, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2019
Quasi-Mendelian paternal inheritance of mitochondrial DNA: A notorious artifact, or anticipated behavior?Sofia Annis, Zoe Fleischmann, Mark Khrapko, et al.
Genes|May 28, 2022
Mitochondrial Pseudogenes Suggest Repeated Inter-Species Hybridization among Direct Human AncestorsKonstantin Popadin, Konstantin Gunbin, Leonid Peshkin, et al.
Human Molecular Genetics|July 18, 2022
Dynamics of the most common pathogenic mtDNA variant m.3243A > G demonstrate frequency-dependency in blood and positive selection in the germlineMelissa Franco, Sarah J Pickett, Zoe Fleischmann, et al.
The Oncologist|June 24, 2023
A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic CancerKuei-Ting Chen, Russell Madison, Jay Moore, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Co-regulator activity of Mediator of DNA Damage Checkpoint 1 (MDC1) is associated with DNA repair dysfunction and PARP inhibitor sensitivity in lobular carcinoma of the breastJoseph L Sottnik, Madeleine T Shackleford, Camryn S Nesiba, et al.
Cancer Research|January 9, 2026
Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP InhibitionJoseph L Sottnik, Madeleine T Shackleford, Camryn S Nesiba, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
British Journal of Cancer|September 22, 2022
Genomic landscape of pleural and peritoneal mesothelioma tumoursStefanie Hiltbrunner, Zoe Fleischmann, Ethan S Sokol, et al.
The Oncologist|August 17, 2023
Increased KRAS G12C Prevalence, High Tumor Mutational Burden, and Specific Mutational Signatures Are Associated With MUTYH Mutations: A Pan-Cancer AnalysisUmut Disel, Smruthy Sivakumar, Tim Pham, et al.
BMC Bioinformatics|March 21, 2022
3GOLD: optimized Levenshtein distance for clustering third-generation sequencing dataRobert Logan, Zoe Fleischmann, Sofia Annis, et al.
JAMA Network Open|March 23, 2022
Prevalence of UV Mutational Signatures Among Cutaneous Primary TumorsDouglas A Mata, Erik A Williams, Ethan Sokol, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2019
Quasi-Mendelian paternal inheritance of mitochondrial DNA: A notorious artifact, or anticipated behavior?Sofia Annis, Zoe Fleischmann, Mark Khrapko, et al.
Genes|May 28, 2022
Mitochondrial Pseudogenes Suggest Repeated Inter-Species Hybridization among Direct Human AncestorsKonstantin Popadin, Konstantin Gunbin, Leonid Peshkin, et al.
Human Molecular Genetics|July 18, 2022
Dynamics of the most common pathogenic mtDNA variant m.3243A > G demonstrate frequency-dependency in blood and positive selection in the germlineMelissa Franco, Sarah J Pickett, Zoe Fleischmann, et al.
The Oncologist|June 24, 2023
A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic CancerKuei-Ting Chen, Russell Madison, Jay Moore, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Co-regulator activity of Mediator of DNA Damage Checkpoint 1 (MDC1) is associated with DNA repair dysfunction and PARP inhibitor sensitivity in lobular carcinoma of the breastJoseph L Sottnik, Madeleine T Shackleford, Camryn S Nesiba, et al.
Cancer Research|January 9, 2026
Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP InhibitionJoseph L Sottnik, Madeleine T Shackleford, Camryn S Nesiba, et al.
Pageof 2